Cargando…
In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032794/ http://dx.doi.org/10.1186/1532-429X-18-S1-W10 |
| _version_ | 1782455065796149248 |
|---|---|
| author | Biasiolli, Luca Chai, Joshua T Li, Linqing Handa, Ashok Jezzard, Peter Choudhury, Robin Robson, Matthew D |
| author_facet | Biasiolli, Luca Chai, Joshua T Li, Linqing Handa, Ashok Jezzard, Peter Choudhury, Robin Robson, Matthew D |
| author_sort | Biasiolli, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5032794 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50327942016-09-29 In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study Biasiolli, Luca Chai, Joshua T Li, Linqing Handa, Ashok Jezzard, Peter Choudhury, Robin Robson, Matthew D J Cardiovasc Magn Reson Workshop Presentation BioMed Central 2016-01-27 /pmc/articles/PMC5032794/ http://dx.doi.org/10.1186/1532-429X-18-S1-W10 Text en © Biasiolli et al. 2016 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Workshop Presentation Biasiolli, Luca Chai, Joshua T Li, Linqing Handa, Ashok Jezzard, Peter Choudhury, Robin Robson, Matthew D In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title | In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title_full | In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title_fullStr | In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title_full_unstemmed | In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title_short | In-vivo carotid T(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| title_sort | in-vivo carotid t(2) mapping can accurately quantify plaque lipid content to discriminate between symptomatic and asymptomatic patients: histological validation, scan-rescan reproducibility and clinical study |
| topic | Workshop Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032794/ http://dx.doi.org/10.1186/1532-429X-18-S1-W10 |
| work_keys_str_mv | AT biasiolliluca invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT chaijoshuat invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT lilinqing invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT handaashok invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT jezzardpeter invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT choudhuryrobin invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy AT robsonmatthewd invivocarotidt2mappingcanaccuratelyquantifyplaquelipidcontenttodiscriminatebetweensymptomaticandasymptomaticpatientshistologicalvalidationscanrescanreproducibilityandclinicalstudy |